Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1918 of 6351
-
Can a natural supplement soothe chemo nerve damage?
Symptom relief OngoingThis phase II trial tests whether PEA works to relieve the symptoms of chemotherapy-induced peripheral neuropathy in patients with cancer. Chemotherapy-induced peripheral neuropathy refers to a nerve problem that causes pain, numbness, tingling, or muscle weakness in different pa…
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Brain aneurysm showdown: which treatment works best?
Disease control Recruiting nowIntracranial aneurysms located on the middle cerebral artery (MCA) are considered by many surgeons to represent a distinct subgroup of aneurysms for which clipping may still be the best management option. Most MCA aneurysms are accessible, proximal control can readily be secured …
Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a single workout shield damaged muscles? a new trial investigates
Knowledge-focused CompletedThe repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques…
Sponsor: Mads Peter Godtfeldt Stemmerik • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New sinus implant aims to unblock noses and ease facial pain
Symptom relief CompletedMulticenter, phase III, randomized, blinded, controlled, parallel group.
Phase 3 • Sponsor: Lyra Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Could a ketone drink help fight colorectal cancer? a trial investigates
Knowledge-focused OngoingThe aim of this study is to assess the feasibility of beta-hydroxybutyrate (BHB) supplementation in individuals who are undergoing a standard-of-care colonoscopy or flexible sigmoidoscopy.
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
New Antibody-Chemo cocktail shows promise for tough lung cancers
Disease control CompletedPhase II open label, multicenter study to evaluate the efficacy and safety of AK104 (anti-PD-1 and CTLA-4 bispecific antibody) combined with Docetaxel in Advanced Non-Small Cell Lung Cancer whose disease has progressed after prior platinum doublet chemotherapy and anti-PD-1/PD-L1…
Phase 2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Light therapy may restore smiles after jaw Surgery—A trial tests two devices
Symptom relief CompletedThis randomized clinical trial compared two photobiomodulation systems for the management of postoperative facial nerve dysfunction following temporomandibular joint surgery. Patients who developed clinically detectable facial nerve dysfunction after open temporomandibular joint …
Sponsor: Ankara University • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New hope for young lupus patients: drug trial targets kidney damage
Disease control Recruiting nowThis phase II, randomized, double-blind, placebo-controlled study is designed to evaluate the safety, efficacy and pharmacokinetics (PK) of obinutuzumab in adolescent participants (AP) aged 12 to less than 18 with biopsy-confirmed proliferative lupus nephritis (LN). It will also …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo attack on stubborn head and neck cancers enters early human testing
Disease control Recruiting nowThis phase I trial is to find out the possible side effects of pembrolizumab and radiation therapy before and during surgery in treating patients with head and neck squamous cell cancer that remains despite treatment (persistent) or has come back (recurrent). Immunotherapy with m…
Phase 1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a headset ease depression at home?
Symptom relief CompletedA two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder when used at home. Participants perform up to 36 tDCS sessions by themselves without supervision du…
Sponsor: Flow Neuroscience AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a Nurse-Led support program ease Families' trauma after ICU?
Disease control CompletedBackground: Family members of critically ill patients face considerable uncertainty and distress during their close other's intensive care unit (ICU) stay, with about 20-60% of family members experiencing post-traumatic distress post-ICU. Guidelines recommend structured family in…
Sponsor: Rahel Naef • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Wearable sensors may personalize balance rehab for older adults — a trial puts them to the test
Symptom relief Recruiting nowThe proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary eff…
Sponsor: University of Montana • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Electric field therapy for brain tumors: a new hope?
Disease control Recruiting nowThis clinical trial tests the safety and side effects of tumor treating fields in treating patients with gliomas located in the brainstem. Optune is a wearable, portable, treatment that creates low-intensity, wave-like electric fields called tumor treating fields (TTFields), whic…
Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New targeted drug shows promise for Hard-to-Treat breast cancers
Disease control Recruiting nowThe main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Participation could last up to 36 …
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Breathing new life: rehab program aims to ease lingering symptoms after blood clots in lungs
Symptom relief Recruiting nowPulmonary Embolism (PE) is a common and serious disease. Indeed, the annual incidence is 1/1000 patients per year and the 3-month mortality is 10%, which is twice that of myocardial infarction. The treatment is based on anticoagulation for at least 3 months. However, after three …
Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can VR games ease phantom limb pain? new study says maybe
Symptom relief CompletedAfter amputation of an arm or leg, up to 90% of subjects experience a "phantom limb", a phenomenon characterized by persistent feelings of the missing limb. Many subjects with a phantom limb experience intense pain in the missing extremity that is often poorly responsive to medic…
Sponsor: Albert Einstein Healthcare Network • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Brain pacemaker tweak could help stroke and tremor patients speak and swallow better
Symptom relief Recruiting nowThis study aims to recruit patients already implanted with Deep Brain Stimulation (DBS) for movement disorders to complete tasks assessing parameters of motor output, speech, and swallowing functions, both with and without stimulation. DBS parameters would be adjusted prior to mo…
Sponsor: Jorge Gonzalez-Martinez • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Battle of the devices: which tool best mends a broken spleen?
Disease control CompletedOur aim is to conduct a multi-center, Bayesian, randomized clinical trial to evaluate the primary technical success of coils and vascular plugs for proximal splenic artery embolization in the setting of high-grade splenic trauma. The investigator has previously demonstrated the f…
Sponsor: Andrew J. Gunn • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Radioactive drug lutathera takes on brain cancer in early trial
Disease control OngoingA Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma as a Single Agent
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New PET scan could spot hidden diseases early
Diagnosis Recruiting nowThis prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinic…
Phase 1/2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC